Literature DB >> 20413902

Recruitment of casein kinase 2 is involved in AbetaPP processing following cholinergic stimulation.

Silvia C Lenzken1, Serena Stanga, Cristina Lanni, Fabio De Leonardis, Stefano Govoni, Marco Racchi.   

Abstract

The amyloid-beta protein precursor (AbetaPP) is an integral membrane protein subjected to constitutive and regulated proteolytic processing. We have previously demonstrated that protein kinase C epsilon (PKCepsilon) plays a key role in the regulation of AbetaPP metabolism via cholinergic receptors. The purpose of the present work is to clarify whether other putative signaling systems are involved in the same pharmacological pathway. We focused particularly on casein kinase 2 (CK2), demonstrating a direct interaction between PKCepsilon and CK2 following cholinergic stimulation. Treatment of human neuroblastoma SH-SY5Y cells with a selective inhibitor of CK2 reduced the effect of carbachol on the release of sAbetaPPalpha. This treatment did not influence the activation and translocation of PKCepsilon suggesting that the latter is located upstream of CK2. On the basis of our results, we add another player to the complex cellular mechanisms regulating non-amyloidogenic processing of AbetaPP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413902     DOI: 10.3233/JAD-2010-090232

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

Review 1.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

2.  Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.

Authors:  Andrea F N Rosenberger; Riet Hilhorst; Elisabeth Coart; Leandro García Barrado; Faris Naji; Annemieke J M Rozemuller; Wiesje M van der Flier; Philip Scheltens; Jeroen J M Hoozemans; Saskia M van der Vies
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 3.  CK2-An Emerging Target for Neurological and Psychiatric Disorders.

Authors:  Julia Castello; Andre Ragnauth; Eitan Friedman; Heike Rebholz
Journal:  Pharmaceuticals (Basel)       Date:  2017-01-05

Review 4.  Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington's Disease.

Authors:  Angel White; Anna McGlone; Rocio Gomez-Pastor
Journal:  Biomedicines       Date:  2022-08-15

5.  Regulation of amyloid precursor protein processing by serotonin signaling.

Authors:  Anna A Pimenova; Amantha Thathiah; Bart De Strooper; Ina Tesseur
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

6.  Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer's disease pathology.

Authors:  Andrea F N Rosenberger; Tjado H J Morrema; Wouter H Gerritsen; Elise S van Haastert; Hripsime Snkhchyan; Riet Hilhorst; Annemieke J M Rozemuller; Philip Scheltens; Saskia M van der Vies; Jeroen J M Hoozemans
Journal:  J Neuroinflammation       Date:  2016-01-06       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.